cycloheximide has been researched along with prostaglandin a1 in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
Abdel-Malek, ZA; Amornsiripanitch, N; Nordlund, JJ; Swope, VB | 1 |
Elia, G; Rossi, A; Santoro, MG | 1 |
Amici, C; Belardo, G; Rossi, A; Santoro, MG | 1 |
Levine, L | 1 |
5 other study(ies) available for cycloheximide and prostaglandin a1
Article | Year |
---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
In vitro modulation of proliferation and melanization of S91 melanoma cells by prostaglandins.
Topics: 1-Methyl-3-isobutylxanthine; Alprostadil; Bucladesine; Cell Division; Cycloheximide; Dactinomycin; Dinoprostone; In Vitro Techniques; Melanins; Melanoma; Monophenol Monooxygenase; Prostaglandin D2; Prostaglandins; Prostaglandins A; Prostaglandins D; Prostaglandins E | 1987 |
Inhibition of nuclear factor kappa B by prostaglandin A1: an effect associated with heat shock transcription factor activation.
Topics: Cycloheximide; DNA-Binding Proteins; Eicosanoids; Gene Expression Regulation; Gene Expression Regulation, Viral; Heat Shock Transcription Factors; HIV Long Terminal Repeat; HIV-1; Humans; NF-kappa B; Phosphorylation; Prostaglandins A; Protein Synthesis Inhibitors; Proto-Oncogene Proteins; Transcription Factor RelB; Transcription Factors; Transcription, Genetic; Tumor Cells, Cultured | 1997 |
Activation of I kappa b kinase by herpes simplex virus type 1. A novel target for anti-herpetic therapy.
Topics: Acyclovir; Animals; Anti-Inflammatory Agents, Non-Steroidal; Antiviral Agents; Chlorocebus aethiops; Cycloheximide; Dactinomycin; Drug Design; Enzyme Activation; Enzyme Inhibitors; Gene Expression Regulation, Fungal; Herpesvirus 1, Human; Humans; I-kappa B Kinase; Kinetics; Laryngeal Neoplasms; Methionine; Neuroblastoma; NF-kappa B; Prostaglandins A; Protein Serine-Threonine Kinases; Recombinant Proteins; Transfection; Tumor Cells, Cultured; Vero Cells; Virus Replication | 2001 |
Stimulated release of arachidonic acid by agonists of the peroxisome proliferator-activated receptor and retinoic acid receptors.
Topics: Alitretinoin; Animals; Anti-Inflammatory Agents, Non-Steroidal; Arachidonic Acid; Celecoxib; Cell Line; Cycloheximide; Dactinomycin; Dose-Response Relationship, Drug; Drug Synergism; Indomethacin; Kinetics; Liver; Prostaglandin D2; Prostaglandins A; Pyrazoles; Rats; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Sulfonamides; Thiazoles; Thiazolidinediones; Transcription Factors; Tretinoin | 2001 |